Connect Biopharma Holdings (CNTB) EBIAT (2024 - 2025)
Connect Biopharma Holdings' EBIAT history spans 2 years, with the latest figure at -$17.2 million for Q3 2025.
- For Q3 2025, EBIAT fell 33.58% year-over-year to -$17.2 million; the TTM value through Sep 2025 reached -$49.3 million, changed N/A, while the annual FY2024 figure was -$15.6 million, 74.84% up from the prior year.
- EBIAT for Q3 2025 was -$17.2 million at Connect Biopharma Holdings, down from -$12.9 million in the prior quarter.
- Across five years, EBIAT topped out at $14.8 million in Q2 2024 and bottomed at -$17.2 million in Q3 2025.